Literature DB >> 8670191

Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli.

G Siemeister1, B Schnurr, K Mohrs, C Schächtele, D Marmé, G Martiny-Baron.   

Abstract

Vascular endothelial growth factor (VEGF) was identified as an endothelial cell specific mitogen that induces angiogenesis and vascular permeability in vivo. VEGF is a homodimeric protein which contains three intramolecular and two intermolecular disulfide bridges. Here, we report on an efficient procedure for recombinant production of VEGF isoforms VEGF121 and VEGF165 in Escherichia coli. The proteins were solubilized from inclusion bodies, refolded, and purified by chromatographic methods. The final protein products were almost completely in the dimeric conformation, bound to VEGF receptor FLT1 with a Kd of 30 pM, stimulated proliferation of human umbilical vein endothelial cells half-maximally at a concentration of 30 pM, and induced in vivo neovascularization and vascular permeability on the chicken chorioallantoic membrane.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670191     DOI: 10.1006/bbrc.1996.0730

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Extending foldamer design beyond α-helix mimicry: α/β-peptide inhibitors of vascular endothelial growth factor signaling.

Authors:  Holly S Haase; Kimberly J Peterson-Kaufman; Sheeny K Lan Levengood; James W Checco; William L Murphy; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2012-05-01       Impact factor: 15.419

2.  Enhancing peptide ligand binding to vascular endothelial growth factor by covalent bond formation.

Authors:  Bernadette V Marquez; Heather E Beck; Tolulope A Aweda; Brett Phinney; Cynthia Holsclaw; William Jewell; Diana Tran; Jeffrey J Day; Malalage N Peiris; Charles Nwosu; Carlito Lebrilla; Claude F Meares
Journal:  Bioconjug Chem       Date:  2012-05-04       Impact factor: 4.774

3.  Purification and refolding of vascular endothelial growth factor-B.

Authors:  S D Scrofani; L J Fabri; P Xu; P Maccarone; A D Nash
Journal:  Protein Sci       Date:  2000-10       Impact factor: 6.725

4.  Early events of metastasis in the microcirculation involve changes in gene expression of cancer cells. Tracking mRNA levels of metastasizing cancer cells in the chick embryo chorioallantoic membrane.

Authors:  T Shioda; L L Munn; M H Fenner; R K Jain; K J Isselbacher
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

5.  An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells.

Authors:  G Siemeister; M Schirner; P Reusch; B Barleon; D Marmé; G Martiny-Baron
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

6.  Expression and characterization of recombinant human VEGF165 in the middle silk gland of transgenic silkworms.

Authors:  Tianyang Zhang; Rongpeng Liu; Qin Luo; Dawei Qu; Tao Chen; Ou Yao; Hanfu Xu
Journal:  Transgenic Res       Date:  2019-09-20       Impact factor: 2.788

7.  Expression and Characterization of Human Vascular Endothelial Growth Factor Produced in SiHa Cells Transduced with Adenoviral Vector.

Authors:  N C Parra; R Mansilla; G Aedo; N S Vispo; E E González-Horta; I González-Chavarría; C Castillo; F Camacho; O Sánchez
Journal:  Protein J       Date:  2019-12       Impact factor: 2.371

8.  A fluorescence polarization assay for identifying ligands that bind to vascular endothelial growth factor.

Authors:  Kimberly J Peterson; Jack D Sadowsky; Elizabeth A Scheef; Soumen Pal; Katerina D Kourentzi; Richard C Willson; Emery H Bresnick; Nader Sheibani; Samuel H Gellman
Journal:  Anal Biochem       Date:  2008-03-28       Impact factor: 3.365

9.  The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo.

Authors:  H T Zhang; P A Scott; L Morbidelli; S Peak; J Moore; H Turley; A L Harris; M Ziche; R Bicknell
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

10.  Development of an aptamer-based affinity purification method for vascular endothelial growth factor.

Authors:  Maren Lönne; Svenja Bolten; Antonina Lavrentieva; Frank Stahl; Thomas Scheper; Johanna-Gabriela Walter
Journal:  Biotechnol Rep (Amst)       Date:  2015-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.